General Information
Version
DRE-C16920000 - Sebuthylazine
Revision date
2023-11-08
Product name
Sebuthylazine
Substance name
C9H16ClN5
CAS No.
7286-69-3
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC GmbH
Emergency telephone
1-800-424-9300, +493030686700, +1 703-741-5970
Icons in SDS
Company Information
company name
LGC GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@lgc-germany.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H373, H411
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Sebuthylazine
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction H373 - May cause damage to organs through prolonged or repeated exposure H411 - Toxic to aquatic life with long lasting effects
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapours/spray P273 - Avoid release to the environment P280 - Wear protective gloves P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P391 - Collect spillage
2.3 Other hazards
Toxic to aquatic life. This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation Category 1 - (H317) Specific target organ toxicity — repeated exposure Category 2 - (H373) Chronic aquatic toxicity Category 2 - (H411)
